Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency-Reference-Cited by-同舟云学术

Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency

Published:2015-08 Issue: Volume:62 Page:39-44
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

van Schaarenburg Rosanne A.,Schejbel Lone,Truedsson Lennart,Topaloglu Rezan,Al-Mayouf Sulaiman M.,Riordan Andrew,Simon Anna,Kallel-Sellami Maryam,Arkwright Peter D.,Åhlin Anders,Hagelberg Stefan,Nielsen Susan,Shayesteh Alexander,Morales Adelaida,Tam Schuman,Genel Ferah,Berg Stefan,Ketel Arnoldus G.,Merlijn van den Berg J.,Kuijpers Taco W.,Olsson Richard F.,Huizinga Tom W.J.,Lankester Arjan C.,Trouw Leendert A.

Funder

IMI JU

VIDI

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference37 articles.

1. C1q and systemic lupus erythematosus;Walport;Immunobiology,1998

2. Complement deficiency and autoimmunity;Walport;Ann. N. Y. Acad. Sci.,1997

3. Clinical and immunological studies in a case of selective complete C1q deficiency;Berkel;Clin. Exp. Immunol.,1979

4. A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual;McAdam;Immunogenetics,1988

5. Molecular basis of hereditary C1q deficiency–revisited: identification of several novel disease-causing mutations;Schejbel;Genes. Immun.,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System Inflammation;Journal of Clinical Immunology;2024-08-28

2. Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation;Proceedings of the National Academy of Sciences;2023-12-04

3. Complement in Human Brain Health: Potential of Dietary Food in Relation to Neurodegenerative Diseases;Foods;2023-09-26

4. RLS-0071, a dual-targeting anti-inflammatory peptide - biomarker findings from a first in human clinical trial;Translational Medicine Communications;2023-01-06

5. The yin and the yang of early classical pathway complement disorders;Clinical and Experimental Immunology;2022-06-01